Elsewhere correspondence
Kenneth M. Gibson, A. F. Hofmann, K. R. Palmerm – 1 July 1987
Chronic liver disease. Edited by M. U. Dianzani and P. Gentilini. 280 pp. Basel, Switzerland: Karger, 1986. $130.75.
Nicholas J. Talley – 1 July 1987
Acidifying enemas (lactitol and lactose) vs. nonacidifying enemas (tap water) to treat acute portal‐systemic encephalopathy: A double‐blind, randomized clinical trial
Misael Uribe, Octavio Campollo, Florencia Vargas, Gian Paolo Ravelli, Fernando Mundo, Laura Zapata, Sofia Gil, Guillermo Garcia‐Ramos – 1 July 1987 – A double‐blind, controlled trial to study the efficacy of acidifying enemas of lactitol, a new galactoside‐sorbitol disaccharide, and lactose vs. nonacidifying tapwater enemas was performed in 45 episodes of acute portal‐systemic encephalopathy. At the time of randomization, all patients had encephalopathy of at least Grade 2+ severity, delay in the performance of number connection tests and hyperammonemia.
Treatment of hepatocellular carcinoma by simultaneous embolization of the hepatic artery and the portal veins
Charles J. Lightdale – 1 July 1987 – Transcatheter arterial embolization (TAE) is an effective means of treatment in primary hepatocellular carcinoma (HCC). However, in many cases of HCC the tumor recurs after treatment. In an attempt to obtain complete tumor necrosis, the authors studied the clinical and histologic effect of simultaneous embolization of both the hepatic artery and portal vein in ten patients with HCC.
Notices
1 July 1987
Sclerotherapy vs. Distal splenorenal shunt in the elective treatment of variceal hemorrhage: A randomized controlled trial
Josep Terés, Josep M. Bordas, Dolores Bravo, Josep Visa, Luis Grande, Juan Carlos Garcia‐Valdecasas, Cristóbal Pera, Joan Rodés – 1 May 1987 – One hundred and twelve consecutive Child Class A and B cirrhotic patients were included in a prospective controlled trial aimed at investigating the efficacy and safety of endoscopic sclerotherapy vs. distal splenorenal shunt in the elective treatment of hemorrhage from esophagogastric varices. Fifty‐seven patients were randomly allocated to splenorenal shunt and 55 to endoscopic sclerotherapy.
The effects of galactosamine‐induced hepatic failure upon blood‐brain barrier permeability
Warren D. Lo, Steven R. Ennis, Gary W. Goldstein, David L. McNeely, A. Lorris Betz – 1 May 1987 – The role of changes in blood‐brain barrier permeability in the pathogenesis of hepatic encephalopathy remains uncertain. To test the hypothesis that brain microvessel permeability is nonselectively increased in hepatic encephalopathy we measured the blood‐brain barrier permeability‐surface area product in rats with acute liver failure induced by intraperitoneal injection of galactosamine.
Spot‐blot hybridization assay for the detection of hepatitis b virus dna in serum: Factors determining its sensitivity and specificity
Eike Walter, Hubert E. Blum, Wolf‐Bernhard Offensperger, Christine Zeschnigk, Silke Offensperger, Wolfgang Gerok – 1 May 1987 – Factors determining the sensitivity and specificity of the spot‐blot hybridization technique for the detection of hepatitis B virus DNA in serum were systematically investigated. Methods for pretreatment of serum samples, mode of application of the samples to the transfer membranes, blot treatment and hybridization conditions were all found to affect the sensitivity of the assay.
Hepatitis b virus replication in acute hepatitis B, acute hepatitis B virus‐hepatitis delta virus coinfection and acute hepatitis delta superinfection
J. Genesca, R. Jardi, M. Buti, L. Vives, S. Prat, J. I. Esteban, R. Esteban, J. Guardia – 1 May 1987 – To evaluate the effect of hepatitis delta virus on the level of replication of hepatitis B virus and to assess the clinical significance that such an effect might have on the final outcome of the infection, the serological profile of hepatitis B virus DNA was investigated in 153 patients with acute or chronic hepatitis B virus infection with or without associated delta infection.